FDA Approves Eohilia for Eosinophilic Esophagitis

FRIDAY, Feb. 16, 2024 -- The U.S. Food and Drug Administration has approved Eohilia (budesonide oral suspension) as the first and only oral treatment for eosinophilic esophagitis (EoE). The oral corticosteroid therapy is approved for individuals...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news